KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gilead Sciences (GILD) Gains from Investment Securities (2016 - 2025)

Gilead Sciences (GILD) has disclosed Gains from Investment Securities for 17 consecutive years, with -$11.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Gains from Investment Securities rose 81.36% year-over-year to -$11.0 million, compared with a TTM value of -$2.0 million through Dec 2025, up 99.43%, and an annual FY2025 reading of -$2.0 million, up 99.43% over the prior year.
  • Gains from Investment Securities was -$11.0 million for Q4 2025 at Gilead Sciences, down from $133.0 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $423.0 million in Q3 2023 and bottomed at -$1.0 billion in Q4 2023.
  • Average Gains from Investment Securities over 5 years is -$128.2 million, with a median of -$76.0 million recorded in 2022.
  • The sharpest move saw Gains from Investment Securities soared 405.26% in 2021, then crashed 1698.04% in 2024.
  • Year by year, Gains from Investment Securities stood at -$557.0 million in 2021, then skyrocketed by 89.05% to -$61.0 million in 2022, then plummeted by 1611.48% to -$1.0 billion in 2023, then skyrocketed by 94.35% to -$59.0 million in 2024, then surged by 81.36% to -$11.0 million in 2025.
  • Business Quant data shows Gains from Investment Securities for GILD at -$11.0 million in Q4 2025, $133.0 million in Q3 2025, and -$33.0 million in Q2 2025.